# Corcept Therapeutics Incorporated (NASDAQ: CORT), Menlo Park, CA – FDA Inspections

Source: https://www.keypedia.com/companies/corcept-therapeutics-incorporated/9f3284cd-b285-4408-818e-19b78043d2e3

> Inspection records and compliance data for Corcept Therapeutics Incorporated in Menlo Park, California. 4 FDA inspections on record, last inspected October 24, 2025. Publicly traded as NASDAQ: CORT.

---

## Details

- Name: Corcept Therapeutics Incorporated
- FEI Number: 3005389393
- Address Line 1: 149 Commonwealth Dr
- City: Menlo Park
- State: California
- Zip Code: 94025
- Country Name: United States
- Address: 149 Commonwealth Dr, Menlo Park, California 94025, United States
- Country: United States

## Stock

- Stock ticker: CORT
- Exchange: NASDAQ
- Share price: $73.71
- Market cap: $8.1B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1291250 - Corcept Therapeutics Incorporated - 2025-10-24 — source: FDA, date: October 24, 2025
- FDA Inspection 1291250 - Corcept Therapeutics Incorporated - 2025-10-24 — classification: No Action Indicated (NAI), source: FDA, date: October 24, 2025
- FDA Inspection 1271321 - Corcept Therapeutics Incorporated - 2025-05-19 — source: FDA, date: May 19, 2025
- FDA Inspection 1271321 - Corcept Therapeutics Incorporated - 2025-05-19 — classification: No Action Indicated (NAI), source: FDA, date: May 19, 2025
- [EIR - Corcept Therapeutics Incorporated - 2020-10-19](https://www.keypedia.com/records/eir/corcept-therapeutics-incorporated/091c22e1-723e-4553-92ad-938fdb56795d) — source: FDA, date: October 19, 2020
- FDA Inspection 1135596 - Corcept Therapeutics Incorporated - 2020-10-19 — classification: No Action Indicated (NAI), source: FDA, date: October 19, 2020
- [483 - Corcept Therapeutics Incorporated - 2014-05-09](https://www.keypedia.com/records/483/corcept-therapeutics-incorporated/e29fa5e1-8f62-47d4-8233-2c983ef5b68f) — source: FDA, date: May 9, 2014
- FDA Inspection 879842 - Corcept Therapeutics Incorporated - 2014-05-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2014
- [FDA Inspection 879842 - Corcept Therapeutics Incorporated - 2014-05-09](https://www.keypedia.com/records/fda_inspections/corcept-therapeutics-incorporated/cbac0b44-e380-4521-b273-0ac439125157) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2014

## Related Companies

- [Sant P. Chawla, MD](https://www.keypedia.com/companies/sant-p-chawla-md/12b13bee-4e0f-4d72-a3a7-217e48fb68ef)
- [Omega Tech Labs, LLC](https://www.keypedia.com/companies/omega-tech-labs-llc/85cf5888-6344-4179-9b59-4610833d6f11)
- [Takeda Pharmaceuticals USA, Inc.](https://www.keypedia.com/companies/takeda-pharmaceuticals-usa-inc/678d8802-0216-41d5-bdd6-38999c144876)
- [Donald J Garcia, Jr. M.D.](https://www.keypedia.com/companies/donald-j-garcia-jr-md/a9185c7c-8af7-4f76-83f6-d313765a3dae)
- [Teva Branded Pharmaceutical Products R&D](https://www.keypedia.com/companies/teva-branded-pharmaceutical-products-rd/7e833f16-5791-422a-944a-bf999e8b8885)
- [Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe](https://www.keypedia.com/companies/caribe-holdings-cayman-co-ltd-dba-puracap-caribe/e746116a-a57b-4872-a647-5ea6d497ff3e)
- [Sunandana Chandra, M.D.](https://www.keypedia.com/companies/sunandana-chandra-md/a091d168-e82f-4647-bf29-22c91ba6fc32)
- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/5198bc9c-156b-4adf-ab9d-7ca6271a62bb)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928)
- [Syneos Health](https://www.keypedia.com/companies/syneos-health/a2842cea-ef97-4a3d-92be-6af32c00ccaf)

## Related Officers

- [Anh M. Lac](https://www.keypedia.com/people/anh-m-lac/20a897c2-ad8c-4bea-8060-34ba80d64d1e)
- [investigator](https://www.keypedia.com/people/thea-c-grome/ff1a4a19-f74c-485a-a177-f4cc5c5b7499)
